Hot Features
Premium
Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Período:
Tipo de Línea:
| Volume | 0 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Biocept Inc | BIOC | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4349 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.4349 | 0.4349 |
| Operaciones | Volume Operado de la Acción | Volumen promedio |
|---|---|---|
| 0 | 0 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| - | 0 | US$ 0.4349 | USD |
Información Financiera Biocept Inc BIOC
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| US$ 1.14M | - | - | - | -31.46 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Biocept Inc BIOC
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 20/10/2023 | 05:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/10/2023 | 07:53 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/9/2023 | 07:00 | Business Wire | Enrollment Completed in the Feasibility Phase of the FORESEE.. |
| 08/9/2023 | 07:00 | Business Wire | Biocept Signs CNSide™ Licensing Agreement with Plus.. |
| 05/9/2023 | 07:00 | Business Wire | Biocept to Participate in the H.C. Wainwright Global.. |
| 25/8/2023 | 07:00 | Business Wire | Biocept to Hold Business Update Conference Call on August.. |
| 22/8/2023 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/8/2023 | 15:05 | Business Wire | Biocept Reports Second Quarter 2023 Financial Results |
| 14/8/2023 | 07:00 | Business Wire | Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two.. |
| 13/7/2023 | 17:15 | Business Wire | Biocept Announces the Passing of Board Chair M. Faye Wilson |
| 20/6/2023 | 15:15 | Business Wire | Biocept Names Antonino Morales as President and Chief.. |
| 14/6/2023 | 15:05 | Business Wire | Biocept to Present at the Maxim Group Virtual Healthcare.. |
Histórico de Datos BIOC
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
